netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
 
 Search
 Formulary Chapter 7: Obstetrics, Gynaecology, and urinary-tract disorders - Full Section
Notes:

Chapter review date:

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
07.01 Drugs used in obstetrics (0,0)
07.01.01 Prostaglandins and oxytocics (7,2)
07.01.01.01 Drugs affecting the ductus arteriosus (0,0)
Maintenance of patency (0,0)
Closure of ductus arteriosus (0,2)
07.01.02 Mifepristone (1,0)
07.01.03 Myometrial relaxants (5,1)
07.01.04 Drugs for preterm labor (0,0)
07.02 Treatment of vaginal and vulval conditions (0,0)
07.02.01 Preparations for vaginal and vulval changes (0,2)
Topical HRT (4,2)
Non-hormonal preparations (0,1)
07.02.02 Vaginal and vulval infections (0,0)
Fungal infections (4,3)
Other vaginal infections (3,3)
07.03 Contraceptives (0,0)
07.03.01 Combined hormonal contraceptives (9,21)
07.03.01.02 Co-cyprindiol (0,0)
07.03.01.03 Phased formulations standard dose 30 micogram oestrogen (0,0)
07.03.01.04 Low dose oestrogen 20 microgram ethinylestradiol (0,0)
07.03.01.05 Transdermal (standard strength) (0,0)
07.03.01.06 Vaginal rings (low strength (0,0)
07.03.01.07 Copper intra-uterine devices (0,0)
07.03.02 Progestogen-only contraceptives (0,0)
07.03.02.01 Oral progestogen-only contraceptives (3,1)
07.03.02.02 Parenteral progestogen-only contraceptives (3,2)
07.03.02.03 Intra-uterine progestogen-only contraceptive (3,0)
07.03.03 Spermicidal contraceptives (1,2)
07.03.04 Contraceptive devices (0,0)
Intra-uterine devices (0,0)
Other contraceptive devices (0,0)
07.03.05 Emergency Contraception (0,0)
Hormonal methods (2,0)
Intra-uterine device (0,0)
07.04 Drugs for genito-urinary disorders (0,0)
07.04.01 Drugs for urinary retention (0,1)
Alpha-blockers (5,2)
Parasympathomimetics (0,2)
07.04.01.02 5-Alpha reductase inhibitors (0,0)
07.04.02 Drugs for urinary frequency, enuresis, and incontinence (0,1)
Urinary incontinence (9,4)
Nocturnal enuresis (1,0)
antimuscarinics (0,0)
beta3-adrenoceptor agonists (0,0)
botulinum toxin (0,0)
07.04.03 Drugs used in urological pain (0,0)
Alkalinisation of urine (1,2)
Acidification of urine (0,0)
Other preparations for urinary disorders (2,2)
07.04.04 Bladder instillations and urological surgery (1,2)
Urological surgery (2,0)
Maintenance of indwelling urinary catheters (4,0)
Bladder carcinoma (0,0)
Interstitial cystitis (0,0)
07.04.05 Drugs for erectile dysfunction (2,3)
Alprostadil (2,0)
Phosphodiesterase type 5 inhibitors (2,5)
Papaverine and phentolamine (0,2)
07.04.06 Drugs for premature ejaculation (0,0)
Dapoxetine (0,0)
07.05 Drugs used in Gynaecology endocrinology (0,0)
07.05.01 For ovulation induction (0,0)
07.05.01.01 Anti-oestrogens (0,0)
07.05.01.02 Gonadotrophins (0,0)
07.05.03 For ovulation trigger (0,0)
07.05.04 For withdrawal bleeding (0,0)
07.05.05 For hirsutism (0,0)
netFormulary